Oxygenta Pharma 33rd AGM: all 7 resolutions passed including director appointments
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Oxygenta Pharmaceutical held its 33rd AGM on 21 Aug 2026 via video conferencing, 10:30 AM to 11:15 AM. 75 members attended out of 10,308 shareholders on record date. All 7 resolutions passed with about 100% approval. Key items: adoption of FY26 audited standalone financials, re-appointment of Mr. Balasubba Reddy Mamilla (retiring by rotation), appointment of Mr. Amireddy Venkatesu Reddy as Whole-time Director and Mr. Janardhana Reddy Yeddula as Independent Director, approval of material related party transactions with holding company Virupaksha Organics for sale-purchase and loan-guarantee, and ratification of Cost Auditor remuneration for FY27.
Routine AGM business concluded smoothly with near-unanimous shareholder approval. No material surprises, but new director appointments and related party deals with parent noted.